Dr. Reddy’s Custom Pharmaceutical Services (CPS) division has expanded its existing custom service facilities with a new formulation development laboratory in Miyapur, Hyderabad, India. The company says bringing together the existing API development team and the formulation teams at one location will accelerate project timelines, reduce costs and simplify licensing processes for CPS’ pharma customers.

With this expansion, the laboratories will form a Center of Excellence for fully integrated API and formulation development services, including pre-formulation studies, prototype formulation development, process development and optimization.

These development capabilities will are put in place to integrate CPS’ offerings of cGMP supplies for Clinical Trials , Registration batches and commercial manufacture.

“This new Center of Excellence for formulation development services reflects our ongoing focus to better serve our pharma customers. Access to our integrated expertise and resources will bring their Drug Product to market in an even quicker and more cost-efficient manner than before,” said Anurag Roy, vice president, global business head at Dr. Reddy’s CPS.